🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Fantastic Clinical Cancer Research Translations piece from Jacob Berchuck & colleagues on our recent Clinical Cancer Research paper uncovering a stemness signature enriched in cfDNA in lethal AR-altered prostate cancer patients. Pradeep Chauhan Mayo Clinic Radiation Oncology Mayo Clinic Comprehensive Cancer Center Mayo Clinic aacrjournals.org/clincancerres/…

1/ Results from #LITESPARK-003 cohort 1 (1st Line) are out The Lancet Oncology! This phase II trial examined HIF2 inh Belzutifan (BEL) + VEGF TKI Cabozantinib (CABO) in pts w/ 1L advanced ccRCC Check it out: sciencedirect.com/science/articl…

1/ 🧵Excited to share our latest study published in Nature Cancer co-led with amazing co-first authors and friends Tejas Jammihal and Chris Labaki under the exceptional mentorship of Toni Choueiri, MD David Braun Sachet Ashok Shukla nature.com/articles/s4301…

Congratulations to GU Postdoctoral Fellows Marc Machaalani (Marc Machaalani), Rashad Nawfal (Rashad Nawfal, MD), Clara Steiner (Clara Steiner), and Emre Yekedüz (Emre Yekedüz) on receiving Merit Awards for the upcoming ASCO #GU25 Meeting! conquer.org/news/conquer-c…

We are pleased to announce the recipients of 2025 Genitourinary Cancers Symposium Merit Awards to recognize first authors on top-ranking abstracts selected for presentation at the ASCO Genitourinary Cancers Symposium, 2/13–15, in San Francisco. Congrats! brnw.ch/21wQptf

BEST of ASCO #GU25 and what to look for based on abstracts release today 2/10. Top 4 in Kidney/Prostate/Bladder Cancers: Dana-Farber Lank Center for Genitourinary Oncology Bradley McGregor Alicia Morgans, MD, MPH Michael Serzan, MD Wenxin (Vincent) Xu Stephanie Berg Misha Beltran Praful Ravi Alok Tewari joaquim bellmunt Charlene Mantia

Excited to be presenting a plenary session at Digestive Disease Week for the third year! Thrilled to have a presidential plenary, a plenary session, and multiple poster presentations. Grateful for the support of incredible mentors who made this possible! BU/BMC IM Residency Mayo Clinic Gastroenterology & Hepatology

The future of GU oncology is bright! OncLive.com Rana McKay, MD, FASCO JAGarciaMD 𝐂𝐡𝐚𝐧𝐝𝐥𝐞𝐫 𝐏𝐚𝐫𝐤 𝐌𝐃 𝐅𝐀𝐂𝐏

Tour de force presentation on HIF2A expression and clinical outcomes in ccRCC and sarc-Rcc by Dana-Farber Lank Center for Genitourinary Oncology superstar Rashad Nawfal, MD! Sylvan Baca MD PhD (Hiring!) Dana-Farber #FreedmanLab

Spectacular presentation from Dana-Farber Lank Center for Genitourinary Oncology superstar/computational biologist Karl Semaan, MD, MSc. First work to show longitudinal monitoring of NEPC using liquid biopsy! With super mentorship from Sylvan Baca MD PhD (Hiring!) #FreedmanLab

Excellent presentation from the #IMDC superstar lead fellow Razane El Hajj Chehade #RHC assessing low vs low-intermediate substrata of IMDC risk groups! Daniel Heng Sylvan Baca MD PhD (Hiring!) Dana-Farber

So proud of mentees Razane El Hajj Chehade, Karl Semaan, MD, MSc, Rashad Nawfal, MD, and Marc Eid for their fantastic talks at ASCO #GU25. Their translational projects should lead to better outcomes for patients with kidney or prostate cancer.

A Great Honor to present Rashad Nawfal, MD of Dana-Farber Lank Center for Genitourinary Oncology 🇺🇸 who discusses his work done with mentor Toni Choueiri, MD VISIT HIM ATPoster Bd G6 Abstract 539 HIF2a gene expression and clinical outcomes in patients with clear cell renal cell carcinoma with and without sarcomatoid

Some snapshots of our super stars Dana-Farber Lank Center for Genitourinary Oncology post-docs work at #GU25 such as Marc Machaalani Clara Steiner Renee Maria Saliby Rashad Nawfal, MD Emre Yekedüz Karl Semaan, MD, MSc Eddy Saad Razane El Hajj Chehade …..missing many ! OncoAlert Dana-Farber Dana-Farber News

Grateful for Hop S. Tran Cao and Jean-Nicolas Vauthey MD for awesome mentorship! CEA rebound 📈 between preop chemo discontinuation and CLM resection predicts worse recurrence and survival Pts with CEA rebound and RAS/TP53 co-mutation ➡️ median OS of 2.7 yrs MD Anderson Cancer Center SSAT

Just in JAMA Network Open👉Flatiron Health Real world Rx data from >8500 pts w/ mRCC #kidneycancer 👉After 2018, only 38% & 14% of pts received 2nd & 3rd line Rx respectively👇bit.ly/41H22dp Thanks to my mentors Umang Swami Sumanta K. Pal, MD, FASCO Neeraj Agarwal, MD, FASCO Cc OncoAlert UroToday.com

I am absolutely thrilled to have matched at Brigham and Women's Medicine Residents Brigham and Women's Hospital for internal medicine residency! Incredibly grateful to my amazing mentors, colleagues, and friends who have supported me throughout this journey Sylvan Baca MD PhD (Hiring!) #MattFreedman Toni Choueiri, MD #Match2025

Toni Choueiri, MD with an overview of advances in the field of kidney cancer #RCC leading to clinically meaningful progress with adjuvant therapy and personalized vaccines #BioBeirut Lebanese University

Thrilled to share that our global Phase 3 trial of mitapivat in NTDT—where I served as global PI & lead author—has been accepted in The Lancet! A game changer: the first oral disease-modifying therapy in NTDT. Proud this was led from #Lebanon. 🔗 sciencedirect.com/science/articl…

🚨Proud to share our publication in JCO Oncology Practice 🧵International Medical Graduates (IMGs) are underrepresented in invited faculty roles at #ASCO Annual Meetings, despite their contributions to original research! Toni Choueiri, MD Nazli Dizman Ziad Bakouny, MD, MSc IMG Oncologists gilberto lopes